169 related articles for article (PubMed ID: 9337435)
1. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
Jacobson PA; West NJ; Price J; Hutchinson RJ
Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
[TBL] [Abstract][Full Text] [Related]
2. Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration.
Dupuis LL; Sung L; Taylor T; Abdolell M; Allen U; Doyle J; Taddio A
Pharmacotherapy; 2004 May; 24(5):564-73. PubMed ID: 15162890
[TBL] [Abstract][Full Text] [Related]
3. Gentamicin pharmacokinetics in postpartum women with endomyometritis.
Munar MY; Lawson LA; Samuels P; Gibson GA
DICP; 1991 Dec; 25(12):1306-9. PubMed ID: 1815422
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
5. Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation.
Walsh KA; Davis GA; Hayes D; Kuhn RJ; Weant KA; Flynn JD
Transpl Infect Dis; 2011 Dec; 13(6):616-21. PubMed ID: 21794042
[TBL] [Abstract][Full Text] [Related]
6. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
[TBL] [Abstract][Full Text] [Related]
7. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
McDade EJ; Wagner JL; Moffett BS; Palazzi DL
Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
[TBL] [Abstract][Full Text] [Related]
8. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
Vercaigne LM; Ariano RE; Zacharias JM
Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
[TBL] [Abstract][Full Text] [Related]
9. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
[TBL] [Abstract][Full Text] [Related]
10. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
[TBL] [Abstract][Full Text] [Related]
11. The effect of sepsis upon gentamicin pharmacokinetics in neonates.
Lingvall M; Reith D; Broadbent R
Br J Clin Pharmacol; 2005 Jan; 59(1):54-61. PubMed ID: 15606440
[TBL] [Abstract][Full Text] [Related]
12. Correlation of aminoglycoside and vancomycin pharmacokinetic parameters.
Wragge TM; Cooper BE
Ann Pharmacother; 1993 Nov; 27(11):1346-8. PubMed ID: 8286806
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.
Townsend PL; Fink MP; Stein KL; Murphy SG
Crit Care Med; 1989 Feb; 17(2):154-7. PubMed ID: 2914447
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin pharmacokinetics in adults with bacterial endocarditis.
Rosell-Rovira ML; Pou-Clavé L; García-Beltran L; Pascual-Mostaza C
Am J Hosp Pharm; 1994 Jun; 51(11):1429-32. PubMed ID: 7942877
[TBL] [Abstract][Full Text] [Related]
15. Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis.
Downes KJ; Dong M; Fukuda T; Clancy JP; Haffner C; Bennett MR; Vinks AA; Goldstein SL
J Antimicrob Chemother; 2017 Jan; 72(1):254-260. PubMed ID: 27585963
[TBL] [Abstract][Full Text] [Related]
16. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.
Bauer LA; Piecoro JJ; Wilson HD; Blouin RA
Clin Pharm; 1983; 2(3):262-4. PubMed ID: 6883955
[TBL] [Abstract][Full Text] [Related]
17. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
Cropp CD; Davis GA; Ensom MH
Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
[TBL] [Abstract][Full Text] [Related]
20. [Gentamicin pharmacokinetics in term newborn: ¿Is it necessary to systematically monitor plasmatic levels?].
Telechea H; Gesuele J; Grosso P; Galarraga F; Guzzo F; Speranza N; Antúnez F; Nanni L; Giachetto G
Rev Chilena Infectol; 2016 Feb; 33(1):7-11. PubMed ID: 26965871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
